FHIT, a novel modifier gene in pulmonary arterial hypertension

Medicine & Life Sciences

• Type II Bone Morphogenetic Protein Receptors 100%
• Modifier Genes 89%
• Pulmonary Arterial Hypertension 73%
• Histidine 68%
• enzastaurin 40%
• Pulmonary Hypertension 22%
• Drug Repositioning 15%
• Right Ventricular Hypertrophy 7%
• Familial Primary Pulmonary Hypertension 7%
• Vascular Remodeling 6%
• Ventricular Pressure 6%
• Pulmonary Artery 5%
• Smooth Muscle Myocytes 4%
• Small Interfering RNA 4%
• Genes 4%
• Hypoxia 4%
• Fibrosis 4%
• Heart Failure 4%
• Up-Regulation 4%
• Down-Regulation 3%
• RNA 3%
• Blood Pressure 3%
• Mutation 3%
• In Vitro Techniques 2%
• Therapeutics 0%